Bilbao, July 17-18, 2008
Organizers:
http://www.cicbiogune.es/congreso/congreso2_ALPD/index.php
Day 1, July 17, 2008
8:45 – 9:00 Welcoming Remarks
J. Mato. Spain. CICbioGUNE Director
9:00 – 9:30 Special Opening Lecture 1.
J. Rodés. Spain. General Director, Hospital Clinic Barcelona. “Heparorenal syndrome”.
09:30 – 12:45 Session 1: Mechanisms of ALPD
Chaired by: H. Tsukamoto & SC Lu
F. Tacke. Germany. “Chemokines and immune cells in liver injury”
B. Gao. USA. “Interleunkin-6/STAT3 and alcoholic liver disease”
Coffee break: 10:45 – 11:00
M.V. Apte . Australia.“Alcohol and the Pancreas : What’s New?”
R.K. Rao. USA ."Disruption of Intestinal Epithelial Tight Junctions and Barrier Dysfunction
in Alcoholic Endotoxemia".
S. Shukla .USA.“Emerging role of epigenetics in alcoholic liver damage”.
13:00 – 15:30 Poster Viewing Session (60 total) & Lunch
15:30 – 18:30 Session 2 .Cell Death and Cancer
Chaired by: J.C. Fernández-Checa & S. Zakhari
M. Czaja .USA .”Differential regulation of liver injury by JNK1 and JNK2”
N. Kaplowitz. USA. “Dealing with stress in alcoholic liver disease”
A.M. Diehl. USA. "Role of Progenitors in Recovery from Fatty Liver Damage"
A. Lugea. USA. “Endoplasmic Reticulum stress in Alcoholic Pancreatitis”
J. Fernández-Checa. Spain. “Mitochondrial cholesterol paradox in cell death”.
18:30 – 19:00 Special Lecture 2
G. Kunos. USA. NIAAA Scientific Director. "Endocannabinoids and Alcoholic Liver
Disease".
20:00 – 22:00 Reception Dinner
Day 2, July 18, 2008
8:45~9:00 Special Remarks
S. Zakhari.USA.NIAAA
9:00 – 9:30 Special Lecture 3
S. Friedman, Liver Diseases Division Chief, Mount Sinai School of Medicine "Emerging concepts
in hepatic fibrosis; the confluence of genetics and molecular biology"
09:30 – 12:45 Session 3 .Clinical Research
Chaired by: C. McClain & M. Imawari (JSGE, Japan)
S. Kendrick .U.K. . “Susceptibility to Alcoholic Liver Disease”
M. Mitchell .U.S.A .”Treatment of Alcoholic Liver Disease. Who should be treated, how long
should treatment be and which therapy is best."
Coffee break: 10:45 – 11:00
R. Sutton (U.K. – clinical pancreas)
ML. Martínez-Chantar .Spain.”Steatohepatitis and S-Adenosylmethionine. The Affair That Never Ends”
C. McClain. USA. "Cytokine Modulation in the Treatment of Alcoholic Liver Disease."
13:00 – 15:30 Oral presentation of selected posters (15 at 10 min each) & Lunch
Moderated by S. Radaeva and D. Xie
15:30 – 18:30 Session 4 . Biomarkers in ALPD and Cirrhosis
Chaired by: S. Pandol & JM. Mato
M. Suematsu. Japan. “HIF-1 as a regulator of stress-induced adaptation of parenchymal
and nonparenchymal cells in the liver”
D. Seth. Australia. "Novel mechanisms & biomarkers in ALD"
F. Marra .Italy .”Hepatic stellate cell biology and fibrogenesis in staetohepatitis”.
C. Logsdon .USA . "Discovery and Validation of Biomarkers for Pancreatic Disease"
L. Beretta .(USA, Proteomics in liver disease)
18:30 – 19:00 Special Lecture 4
J. Bosch. Spain. Director CIBERehd, Hospital Clinic Barcelona
19:00 – 19:15 Poster Award
G. Esmat (Egypt)
19:15 – 19:45 Closing Remarks International collaboration
20:30 – 23:00 Reception Dinner
Poster Award Committee:
H. Tsukamoto (USA)
H. Ishii (Japan)
S.Pandol (USA)
J.M Mato (Spain)
J.C. Fernández-Checa (Spain)
Poster session moderators:
G. Esmat (Egypt) – poster award
D. Xie (China) – oral abstract session
S. Radaeva (NIAAA) – oral abstract session
Organizing Committee for the meeting:
J.M Mato (Spain)
J.C. Fernandez-Checa (Spain)
S. Lu (USA)
S. Pandol (USA)
Travel Award Committee:
For students and post-docs from the U.S. – Hide Tsukamoto, Stephen Pandol, and Shelly C. Lu
For those from non-U.S. countries- José Mato and José Fernández-Checa
Supported by: NIAAA/NIH, CIBERehd and CICbioGUNE.